Inceptor Bio Employee Directory
Biotechnology ResearchUnited States11-50 Employees
Inceptor Bio is a clinical-stage biotech company pioneering next-generation cell therapies to cure cancer. Our proprietary OUTLAST™ platform reprograms T cells into persistent, stem-like cells capable of thriving in the hostile tumor microenvironment. Our thesis: Like elite athletes training at high elevation, T cells conditioned in challenging environments develop the attributes needed to thrive in the hostile tumor setting, outperforming cells grown in conventional, idealized conditions Our lead program, IB-T101, is an autologous CD70 CAR-T therapy targeting clear cell Renal Cell Carcinoma (ccRCC). Join us on our journey to redefine the future of cancer treatment.